These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19576016)

  • 1. [Celecoxib enhances the lethal effects of bleomycin in human tongue squamous carcinoma cell line Tca8113].
    Li WZ; Wang XY; Li ZG; Zhang JH; Ding YQ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Mar; 44(3):140-3. PubMed ID: 19576016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113].
    Li WZ; Wang XY; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):486-9. PubMed ID: 20335116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effects of COX-2 inhibitor on migration of human tongue squamous cell carcinoma Tca8113 cells].
    Huo QJ; Li WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2194-6. PubMed ID: 19923064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
    Li WZ; Huo QJ; Wang XY; Xu F
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):113-9. PubMed ID: 20709621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
    Li WZ; Wang XY; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):466-8. PubMed ID: 19304526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE; Jeon NK; Kim J; Lee EJ
    Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of celecoxib on the proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2].
    Xu X; Yi F; Fu X; Li D; Huang Q; Du J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Aug; 23(15):682-5. PubMed ID: 19947251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro.
    Li WZ; Wang XY; Li ZG; Zhang JH; Ding YQ
    J Oral Pathol Med; 2010 Aug; 39(7):579-84. PubMed ID: 20202090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3].
    Xu S; Zhou WQ; Zhang ZY; Ge JP; Gao JP
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):489-93. PubMed ID: 18649743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells.
    Chen PY; Long QC
    Acta Pharmacol Sin; 2004 Jul; 25(7):943-9. PubMed ID: 15210070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Celecoxib promotes apoptosis of breast cancer cell line MDA-MB-231 through down-regulation of the NF-kappaB pathway].
    Wang L; Liu LH; Shan BE; Zhang C; Sang MX; Li J
    Ai Zheng; 2009 Jun; 28(6):569-74. PubMed ID: 19635192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
    Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
    Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous nuclear ribonuclear protein C is increased in the celecoxib-induced growth inhibition of human oral squamous cell carcinoma.
    Lee EJ; Kim SH; Kwark YE; Kim J
    Exp Mol Med; 2006 Jun; 38(3):203-9. PubMed ID: 16819278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.
    Vivaldi A; Ciampi R; Tacito A; Molinaro E; Agate L; Bottici V; Pinchera A; Collecchi P; Elisei R
    Mol Cell Endocrinol; 2012 May; 355(1):41-8. PubMed ID: 22305971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.